Denver Living  |  Contact Us 


(303) 724-3506
Repro.Sci@UCHSC.edu













FULL FACULTY

Steve Anderson
Russell Anthony
David Bain
Andrew Bradford
John Cambier
Heide Ford
Jed Friedman
Arthur Gutierrez-Hartmann
William Hay
Peter Henson
Michael Holers
Joan Hooper
Kathryn Horwitz
Laurel Lenz
James Maller
Jim McManaman
Lorna Moore
Peggy Neville
Steve Nordeen
Bill Schiemann
Pepper Schedin
Natalie Serkova
Celia Sladek
Ann Thor
Andrew Thorburn
Margaret Wierman
Trevor Williams
Virginia Winn
ADJUNCT FACULTY
Ruben Alvero
Kian Behbakht
Dawn Duval
Henry Galan
L. Michael Glode
Scott Lucia
Anne Lynch
Brian Parr
Marie-France Pfenninger
Jennifer Richer
Kenneth Shroyer


 

Ann D. Thor, M.D.
Professor and Chair

Department of Pathology

M.D. Vanderbilt University School of Medicine (1981)

Campus Box 8104
RC-1 North, Room P18-5131
Phone: 303-724-3704
ann.thor@uchsc.edu

Research Interests:

Markers of breast cancer prognosis or chemotherapeutic response prediction

Mechanisms of carcinogenesis involving the receptor tyrosine kinase gene family

Molecular and epigenetic factors which may contribute to breast cancer susceptibility


Selected Publications


Mungamuri SK, Yang X, Thor AD, Somasundaram K.Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53. Cancer Res. 2006 May 1;66(9):4715-24.

Kim A, Liu B, Ordonez-Ercan D, Alvarez KM, Jones LD, McKimmey C, Edgerton SM, Yang X, Thor AD. Functional interaction between mouse erbB3 and wild-type rat c-neu in transgenic mouse mammary tumor cells. Breast Cancer Res. 2005;7(5):R708-18.

Yang XH, Edgerton S, Thor AD. Reconstitution of caspase-3 sensitizes MCF-7 breast cancer cells to radiation therapy. Int J Oncol. 2005 Jun;26(6):1675-80.

DiGiovanna MP, Stern DF, Edgerton SM, Whalen SG, Moore D 2nd, Thor AD. Relationship of epidermal growth factor receptor expression to ErbB-2 signaling activity and prognosis in breast cancer patients. J Clin Oncol. 2005 Feb 20;23(6):1152-60.

Kosanke S, Edgerton SM, Moore D 2nd, Yang X, Mason T, Alvarez K, Jones L, Kim A, Thor AD. Mammary tumor heterogeneity in wt-ErbB-2 transgenic mice. Comp Med. 2004 Jun;54(3):280-7.

Edgerton SM, Moore D 2nd, Merkel D, Thor AD. erbB-2 (HER-2) and breast cancer progression. Appl Immunohistochem Mol Morphol. 2003 Sep;11(3):214-21.

Yang X, Edgerton SM, Kosanke SD, Mason TL, Alvarez KM, Liu N, Chatterton RT, Liu B, Wang Q, Kim A, Murthy S, Thor AD. Hormonal and dietary modulation of mammary carcinogenesis in mouse mammary tumor virus-c-erbB-2 transgenic mice. Cancer Res. 2003 May 15;63(10):2425-33.

Jeruss JS, Liu NX, Chung Y, Magrane G, Waldman F, Edgerton S, Yang X, Thor AD. Characterization and chromosomal instability of novel derived cell lines from a wt-erbB-2 transgenic mouse model. Carcinogenesis. 2003 Apr;24(4):659-64.


Latest Publications in PubMed



Home    Faculty   Students   Curriculum   Admissions   Events & Seminars   Denver Living   Contact Us
    Copyright © 2005 Program in Reproductive Sciences
    University of Colorado Health Sciences Center